top of page

Kyverna's CEO on B-cell depletion and CD19 CAR-T for autoimmune conditions

Peter Maag describes how Kyverna has been focused on this area for five years and today has clinical experience in diseases as varied as lupus and multiple sclerosis.


Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter
  • LinkedIn
  • Facebook
  • TikTok
  • Instagram

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight


Breakthrough Properties is a life science real estate company that is exclusively focused on delivering cutting-edge environments for the life science industry. With a portfolio of roughly 5 million square feet across the US, UK and continental Europe, Breakthrough has emerged as a leading partner for high-growth biotechs and pharmas around the world. 

bottom of page